Progressive diffuse meningioangiomatosis: Response to bevacizumab treatment

Neurology. 2016 Apr 26;86(17):1643-4. doi: 10.1212/WNL.0000000000002610. Epub 2016 Mar 30.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Angiomatosis / diagnostic imaging
  • Angiomatosis / drug therapy*
  • Angiomatosis / pathology
  • Antineoplastic Agents, Immunological / therapeutic use
  • Bevacizumab / therapeutic use*
  • Humans
  • Male
  • Meninges / pathology*

Substances

  • Antineoplastic Agents, Immunological
  • Bevacizumab